Literature DB >> 29353029

Applying surgical antimicrobial standards in cesarean deliveries.

Kathryn E Fay1, Lynn Yee2.   

Abstract

Antimicrobial prophylaxis practices are critical to surgical site infection risk-reduction strategies. Included in these practices is antibiotic redosing following prolonged procedures or after large blood losses. Guidelines have been published by several professional associations, with most endorsing repeat antibiotic administration after an estimated blood loss of 1500 mL or following 2 half-lives of the select agent. These conventions have been widely adopted by surgeons with the exception of obstetricians at the time of cesarean delivery. This Viewpoint explores existing guidelines, reviews the data for these recommendations, and questions the tradition of abstinence from redosing in cesarean deliveries despite the burden of infection in this cohort.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  antibiotic prophylaxis; cesarean delivery; surgical site infection; surgical wound infection

Mesh:

Substances:

Year:  2018        PMID: 29353029      PMCID: PMC6013077          DOI: 10.1016/j.ajog.2018.01.016

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  27 in total

1.  ACOG practice bulletin No. 104: antibiotic prophylaxis for gynecologic procedures.

Authors: 
Journal:  Obstet Gynecol       Date:  2009-05       Impact factor: 7.661

2.  Visually estimated and calculated blood loss in vaginal and cesarean delivery.

Authors:  Irene Stafford; Gary A Dildy; Steven L Clark; Michael A Belfort
Journal:  Am J Obstet Gynecol       Date:  2008-07-17       Impact factor: 8.661

Review 3.  Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system.

Authors:  Eyal Zimlichman; Daniel Henderson; Orly Tamir; Calvin Franz; Peter Song; Cyrus K Yamin; Carol Keohane; Charles R Denham; David W Bates
Journal:  JAMA Intern Med       Date:  2013 Dec 9-23       Impact factor: 21.873

4.  Comprehensive maternal hemorrhage protocols reduce the use of blood products and improve patient safety.

Authors:  Laurence E Shields; Suzanne Wiesner; Janet Fulton; Barbara Pelletreau
Journal:  Am J Obstet Gynecol       Date:  2014-07-12       Impact factor: 8.661

5.  The second wave: Toward responsible inclusion of pregnant women in research.

Authors:  Anne Drapkin Lyerly; Margaret Olivia Little; Ruth Faden
Journal:  Int J Fem Approaches Bioeth       Date:  2008

6.  End-of-procedure cefazolin concentrations after administration for prevention of surgical-site infection.

Authors:  Erin Koopman; David E Nix; Brian L Erstad; Michael J Demeure; Melinda M Hayes; John T Ruth; Kathryn R Matthias
Journal:  Am J Health Syst Pharm       Date:  2007-09-15       Impact factor: 2.637

7.  Adjunctive Azithromycin Prophylaxis for Cesarean Delivery.

Authors:  Alan T N Tita; Jeff M Szychowski; Kim Boggess; George Saade; Sherri Longo; Erin Clark; Sean Esplin; Kirsten Cleary; Ron Wapner; Kellett Letson; Michelle Owens; Adi Abramovici; Namasivayam Ambalavanan; Gary Cutter; William Andrews
Journal:  N Engl J Med       Date:  2016-09-29       Impact factor: 91.245

8.  Effect of Post-Cesarean Delivery Oral Cephalexin and Metronidazole on Surgical Site Infection Among Obese Women: A Randomized Clinical Trial.

Authors:  Amy M Valent; Chris DeArmond; Judy M Houston; Srinidhi Reddy; Heather R Masters; Alison Gold; Michael Boldt; Emily DeFranco; Arthur T Evans; Carri R Warshak
Journal:  JAMA       Date:  2017-09-19       Impact factor: 56.272

9.  Effects of blood loss and fluid volume replacement on serum and tissue gentamicin concentrations during colorectal surgery.

Authors:  Sophia L Markantonis; Georgia Kostopanagiotou; Dimitris Panidis; Vassilios Smirniotis; Dionisios Voros
Journal:  Clin Ther       Date:  2004-02       Impact factor: 3.393

10.  A comparison between single and double dose intravenous Timentin for the prophylaxis of wound infection in elective colorectal surgery.

Authors:  A M Cuthbertson; A R McLeish; J C Penfold; H Ross
Journal:  Dis Colon Rectum       Date:  1991-02       Impact factor: 4.585

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.